Search Results - Kristopher R. Bosse

Refine Results
  1. 1
    Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

    Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations by Kristopher R. Bosse, John M. Maris

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Genetic susceptibility to neuroblastoma: current knowledge and future directions

    Genetic susceptibility to neuroblastoma: current knowledge and future directions by Laura E. Ritenour, Michael P. Randall, Kristopher R. Bosse, Sharon J. Diskin

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Rare Variants in TP53 and Susceptibility to Neuroblastoma

    Rare Variants in TP53 and Susceptibility to Neuroblastoma by Sharon J. Diskin, Mario Capasso, Maura Diamond, Derek A. Oldridge, Karina L. Conkrite, Kristopher R. Bosse, Mike R. Russell, Achille Iolascon, Hákon Hákonarson, Marcella Devoto, John M. Maris

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    <i>BARD1</i> germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

    <i>BARD1</i> germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma by Michael P. Randall, Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff, Perry Evans, Jo Lynne Rokita, Mehdi Layeghifard, Adam Shlien, John M. Maris, Sharon J. Diskin, Kristopher R. Bosse

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

    RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma by Kristina A. Cole, Jonathan H. Huggins, Michael P. LaQuaglia, Chase E. Hulderman, Mike R. Russell, Kristopher R. Bosse, Sharon J. Diskin, Edward F. Attiyeh, Rachel Sennett, Geoffrey T. Norris, Marci Laudenslager, Andrew Wood, Patrick A. Mayes, Jayanti Jagannathan, Cynthia Winter, Yaël P. Mossé, John M. Maris

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Epigenetic state determines inflammatory sensing in neuroblastoma

    Epigenetic state determines inflammatory sensing in neuroblastoma by Adam J. Wolpaw, Liron D. Grossmann, Jessica L. Dessau, May M. Dong, Bailey J. Aaron, Patricia Brafford, Darya Volgina, Guillem Pascual‐Pasto, Alba Rodríguez-García, Yasin Uzun, Marie Arsenian‐Henriksson, Daniel J. Powell, Kristopher R. Bosse, Andrew V. Kossenkov, Kai Tan, Michael D. Hogarty, John M. Maris, Chi V. Dang

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

    Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors by Jessica Foster, Crystal Griffin, Jo Lynne Rokita, Allison Stern, Cameron Brimley, Komal S. Rathi, Maria Lane, Samantha N. Buongervino, Tiffany Smith, Peter J. Madsen, Daniel Martínez, Alberto Delaidelli, Poul H. Sorensen, Robert J. Wechsler‐Reya, Katalin Karikó, Phillip B. Storm, David M. Barrett, Adam Resnick, John M. Maris, Kristopher R. Bosse

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma

    CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma by Guillem Pascual‐Pasto, Brendan McIntyre, Margaret G. Hines, Anna Maria Giudice, Laura Garcia-Gerique, Jennifer Hoffmann, Pamela Mishra, Stephanie Matlaga, Simona Lombardi, Rawan Shraim, Patrick M. Schürch, Mark Yarmarkovich, Ted J. Hofmann, Fatemeh Alikarami‬, Daniel Martínez, Matthew Tsang, Luis Gil‐de‐Gómez, Timothy T. Spear, Kathrin M. Bernt, Adam J. Wolpaw, Dimiter S. Dimitrov, Wei Li, Kristopher R. Bosse

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma

    Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma by Kristopher R. Bosse, Anna Maria Giudice, Maria Lane, Brendan McIntyre, Patrick M. Schürch, Guillem Pascual‐Pasto, Samantha N. Buongervino, Sriyaa Suresh, Alana Fitzsimmons, Adam Hyman, Maria Gemino-Borromeo, Jennifer Saggio, Esther R. Berko, Alexander A. Daniels, Jennifer Stundon, Megan Friedrichsen, Xin Liu, Matthew Margolis, Marilyn M. Li, Marni Brisson Tierno, Geoffrey R. Oxnard, John M. Maris, Yaël P. Mossé

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

    Common variations in BARD1 influence susceptibility to high-risk neuroblastoma by Mario Capasso, Marcella Devoto, Cuiping Hou, Shahab Asgharzadeh, Joseph Glessner, Edward F. Attiyeh, Yaël P. Mossé, Cecilia Kim, Sharon J. Diskin, Kristina A. Cole, Kristopher R. Bosse, Maura Diamond, Marci Laudenslager, Cynthia Winter, Jonathan P. Bradfield, Richard H. Scott, Jayanti Jagannathan, Maria Garris, Carmel McConville, Wendy B. London, Robert C. Seeger, Struan F.A. Grant, Hongzhe Li, Nazneen Rahman, Eric Rappaport, Hákon Hákonarson, John M. Maris

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Common Variation at<i>BARD1</i>Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity

    Common Variation at<i>BARD1</i>Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity by Kristopher R. Bosse, Sharon J. Diskin, Kristina A. Cole, Andrew Wood, Robert W. Schnepp, Geoffrey T. Norris, Lễ B. Nguyễn, Jayanti Jagannathan, Michael P. LaQuaglia, Cynthia Winter, Maura Diamond, Cuiping Hou, Edward F. Attiyeh, Yaël P. Mossé, Vanessa Pineros, Éva Dizin, Yongqiang Zhang, Shahab Asgharzadeh, Robert C. Seeger, Mario Capasso, Bruce Pawel, Marcella Devoto, Hákon Hákonarson, Eric Rappaport, Irmgard Irminger‐Finger, John M. Maris

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma

    Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma by Josephine G. M. Strijker, Guillem Pascual‐Pasto, Grant Grothusen, Yannine J. Kalmeijer, Elisavet Kalaitsidou, Chunlong Zhao, Brendan McIntyre, Stephanie Matlaga, Lindy L. Visser, Marta Barisa, Courtney Himsworth, Rivani Shah, Henrike Muller, Linda Schild, Peter G. Hains, Qing Zhong, Roger R Reddel, Phillip J. Robinson, Xavier Catena, Marı́a S. Soengas, Thanasis Margaritis, Frank J. Dekker, John Anderson, Jan J. Molenaar, Kristopher R. Bosse, Wei Wu, Judith Wienke

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Copy number variation at 1q21.1 associated with neuroblastoma

    Copy number variation at 1q21.1 associated with neuroblastoma by Sharon J. Diskin, Cuiping Hou, Joseph Glessner, Edward F. Attiyeh, Marci Laudenslager, Kristopher R. Bosse, Kristina A. Cole, Yaël P. Mossé, Andrew Wood, Jill E. Lynch, Katlyn Pecor, Maura Diamond, Cynthia Winter, Kai Wang, Cecilia Kim, Elizabeth A. Geiger, Patrick McGrady, Alexandra I. F. Blakemore, Wendy B. London, Tamim H. Shaikh, Jonathan P. Bradfield, Struan F.A. Grant, Hongzhe Li, Marcella Devoto, Eric Rappaport, Hákon Hákonarson, John M. Maris

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma

    Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma by Kristopher R. Bosse, Pichai Raman, Zhongyu Zhu, Maria Lane, Daniel Martínez, Sabine Heitzeneder, Komal S. Rathi, Nathan M. Kendsersky, Michael P. Randall, Laura Donovan, A. Sorana Morrissy, Robyn T. Sussman, Doncho V. Zhelev, Yang Feng, Yanping Wang, Jennifer Hwang, Gonzalo López, Jo Lynne Harenza, Jun S. Wei, Bruce Pawel, Tricia R. Bhatti, Mariarita Santi, Arupa Ganguly, Javed Khan, Marco A. Marra, Michael D. Taylor, Dimiter S. Dimitrov, Crystal L. Mackall, John M. Maris

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs

    RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs by Mark Yarmarkovich, Quinlen F. Marshall, John M. Warrington, Rasika Premaratne, Alvin Farrel, David Groff, Wei Li, Moreno Di Marco, Erin Runbeck, Hau V. Truong, Jugmohit Toor, Sarvind Tripathi, Son Nguyen, Helena Shen, Tiffany Noel, Nicole L. Church, Amber K. Weiner, Nathan M. Kendsersky, Dan Martinez, Rebecca Weisberg, Molly Christie, Laurence C. Eisenlohr, Kristopher R. Bosse, Dimiter S. Dimitrov, Stefan Stevanović, Nikolaos G. Sgourakis, Ben R. Kiefel, John M. Maris

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Germline pathogenic variants in neuroblastoma patients are enriched in <i>BARD1</i> and predict worse survival

    Germline pathogenic variants in neuroblastoma patients are enriched in <i>BARD1</i> and predict worse survival by Jung Kim, Zalman Vaksman, Laura E. Egolf, Rebecca Kaufman, Perry Evans, Karina L. Conkrite, Arnavaz Danesh, Gonzalo López, Michael P. Randall, Maiah H. Dent, Lance M. Farra, Neil Menghani, Malwina Dymek, Heena Desai, Ryan Hausler, Belynda Hicks, Jaime M. Guidry Auvil, Daniela S. Gerhard, Hákon Hákonarson, Kara N. Maxwell, Kristina A. Cole, Trevor J. Pugh, Kristopher R. Bosse, Javed Khan, Jun S. Wei, John M. Maris, Douglas R. Stewart, Sharon J. Diskin

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Targeting of intracellular oncoproteins with peptide-centric CARs

    Targeting of intracellular oncoproteins with peptide-centric CARs by Mark Yarmarkovich, Quinlen F. Marshall, John M. Warrington, Rasika Premaratne, Alvin Farrel, David Groff, Wei Li, Moreno Di Marco, Erin Runbeck, Hau V. Truong, Jugmohit Toor, Sarvind Tripathi, Son Nguyen, Helena Shen, Tiffany Noel, Nicole L. Church, Amber K. Weiner, Nathan M. Kendsersky, Dan Martinez, Rebecca Weisberg, Molly Christie, Laurence C. Eisenlohr, Kristopher R. Bosse, Dimiter S. Dimitrov, Stefan Stevanović, Nikolaos G. Sgourakis, Ben R. Kiefel, John M. Maris

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Integrative genomics identifies LMO1 as a neuroblastoma oncogene

    Integrative genomics identifies LMO1 as a neuroblastoma oncogene by Kai Wang, Sharon J. Diskin, Haitao Zhang, Edward F. Attiyeh, Cynthia Winter, Cuiping Hou, Robert W. Schnepp, Maura Diamond, Kristopher R. Bosse, Patrick A. Mayes, Joseph Glessner, Cecilia Kim, Edward C. Frackelton, Maria Garris, Qun Wang, Wendy Glaberson, Rosetta Chiavacci, Lễ B. Nguyễn, Jayanti Jagannathan, Norihisa Saeki, Hiroki Sasaki, Struan F.A. Grant, Achille Iolascon, Yaël P. Mossé, Kristina A. Cole, Hongzhe Li, Marcella Devoto, Patrick McGrady, Wendy B. London, Mario Capasso, Nazneen Rahman, Hákon Hákonarson, John M. Maris

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

    GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity by Sabine Heitzeneder, Kristopher R. Bosse, Zhongyu Zhu, Doncho V. Zhelev, Robbie G. Majzner, Molly Radosevich, Shaurya Dhingra, Elena Sotillo, Samantha N. Buongervino, Guillem Pascual‐Pasto, Emily Garrigan, Peng Xu, Jing Huang, Benjamin Salzer, Alberto Delaidelli, Swetha Raman, Hong Cui, Benjamin Martinez, Scott J. Bornheimer, Bita Sahaf, Anya S. Alag, Irfete S. Fetahu, Martin Hasselblatt, Kevin R. Parker, Hima Anbunathan, Jennifer Hwang, Min Huang, Kathleen M. Sakamoto, Norman J. Lacayo, Dorota D. Klysz, Johanna Theruvath, José G. Vilches-Moure, Ansuman T. Satpathy, Howard Y. Chang, Manfred Lehner, Sabine Taschner‐Mandl, Jean‐Philippe Julien, Poul H. Sorensen, Dimiter S. Dimitrov, John M. Maris, Crystal L. Mackall

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

    A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma by Amber K Hamilton, Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Karina L. Conkrite, Khushbu Patel, Simone Sidoli, Alberto Delaidelli, Apexa Modi, Jo Lynne Rokita, Maria Lane, Nicholas Hartnett, Raphael D. Lopez, Bo Zhang, Chuwei Zhong, Brian Ennis, Daniel P. Miller, Miguel Brown, Komal S. Rathi, Pichai Raman, Jennifer Pogoriler, Tricia R. Bhatti, Bruce Pawel, Tina Glisovic‐Aplenc, Beverly A. Teicher, Stephen W. Erickson, Eric J. Earley, Kristopher R. Bosse, Poul H. Sorensen, Kateryna Krytska, Yaël P. Mossé, Karin Havenith, Francesca Zammarchi, Patrick H. van Berkel, Malcolm A. Smith, Benjamin A. Garcia, John M. Maris, Sharon J. Diskin

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: